1. Guo-Min Li  Is a corresponding author
  1. University of Southern California Keck School of Medicine, United States

Errors made when DNA is replicated can lead to cancer and genetic disorders, so cells rely on a system called mismatch repair (MMR) to remove many of the errors from newly synthesized DNA (Hombauer et al., 2011Kunkel and Erie, 2015; Simmons et al., 2008). These errors include mismatches that occur when the wrong DNA base is added into the new DNA strand (i.e. a base that does not match the one in the template strand). MMR must deal with these mistakes before the DNA is repackaged into nucleosomes, which would block the repair mechanisms. As such, a long-standing question in this field is how the MMR system discriminates the new strand (which contains the errors) from the template (which is error-free) both quickly and accurately.

Now, in eLife, Tatsuro Takahashi and colleagues at Osaka University and Kyushu University report a new twist in this story (Kawasoe et al., 2016). Newly synthesized strands of DNA have small gaps or nicks (Kunkel and Erie, 2015), and such signals can be used to direct MMR to a specific DNA strand in cell-free experiments (Holmes et al., 1990). However, Takahashi and colleagues – who include Yoshitaka Kawasoe as first author – found, via experiments with Xenopus cell extracts, that MMR can still correctly identify the new DNA strand even after any gaps or nicks had been filled in. This unexpectedly implied that there must be a second signal that allows MMR in eukaryotes to distinguish the new DNA strand from the template.

So, what is this second signal? PCNA is a ring-shaped complex that acts as a “sliding clamp” to coordinate DNA replication by traveling along the DNA template. Eukaryotes use PCNA and a mismatch recognition complex called MutSα to start MMR (Kadyrov et al., 2006Kunkel and Erie, 2015; Umar et al., 1996), and these two complexes interact directly at the site of a mismatch (Clark et al., 1999; Flores-Rozas et al., 2000; Kleczkowska et al., 2001). Kawasoe et al. now reveal that the PCNA complex provides the secondary signal that allows the cell to “remember” which strand of DNA is which (Figure 1A,B).

PCNA binds to DNA in an asymmetric way.

Base-base mismatches (dashed circle) result when a base is added into a newly synthesized DNA strand (red) that does not match the corresponding base in the template strand (blue). (A) Newly synthesized strands of DNA often have small gaps that are filled in and ligated later, and the ring-shaped complex PCNA forms non-identical complexes with 5’-gapped (top) or 3’-gapped (bottom) heteroduplex DNA. Note that one side of the complex (green) always faces towards the 5’ end of the new DNA strand, while the other (yellow) faces towards the 3’-end. (B) The asymmetry of the PCNA-DNA complexes is conserved after the DNA gaps are filled in and ligated; this could allow DNA mismatch repair to distinguish the error-containing new strand from the error-free template. (C) Kawasoe et al. show that PCNA spends little time on DNA containing a mismatch in the absence of the mismatch recognition complex MutSα (top). PCNA spends much longer on the DNA when MutSα is present (middle), but not quite so long if MutSα’s PCNA interacting protein (PIP) motif is removed (MutSα∆PIP; bottom). Times given in figure are the half-lives of the PCNA-DNA complexes (t1/2).

The PCNA clamp loads onto DNA ends in an asymmetric way (Pluciennik et al., 2010). This means that one side of the ring complex always faces towards the 5’-end of the newly synthesized DNA, while the other faces towards its 3’-end. Kawasoe et al. propose that this inbuilt asymmetry is used to direct the enzymes that correct mismatches towards the new strand and not the template strand.

Kawasoe et al. also found that MutSα strongly encourages the PCNA clamp to remain loaded on the DNA. They showed that this effect was much weaker if MutSα lacked the domain that it uses to interact with PCNA (Figure 1C). These findings further suggest that the interaction between MutSα and PCNA might act in favor of MMR, rather than DNA replication. If, as Kawasoe et al. suggest, the asymmetric PCNA-DNA complex forms a biological “memory” of which DNA strand is which, then the interaction between MutSα and PCNA appears to make that memory more stable over time, similar to converting short-term memories to long-term ones.

However, several questions remain to be answered. For example, the PCNA asymmetry and its interaction with MutSα may create a long-term “memory” for strand-specific MMR, but why do cells delay the packing of DNA into nucleosomes? Also, do the various modifications that are made to PCNA (such as ubiquitination and phosphorylation; Ortega et al., 2015) alter its role in strand-discrimination in MMR? Finally, does MMR in bacteria also use β clamp (the bacterial counterpart of PCNA) in the same way (Simmons et al., 2008)? Additional studies are now needed to answer these important questions.

References

Article and author information

Author details

  1. Guo-Min Li

    Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, United States
    For correspondence
    guominli@usc.edu
    Competing interests
    The author declares that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9842-4578

Publication history

  1. Version of Record published:

Copyright

© 2016, Li

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,199
    views
  • 149
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Guo-Min Li
(2016)
DNA Repair: Clamping down on mismatches
eLife 5:e18365.
https://doi.org/10.7554/eLife.18365
  1. Further reading

Further reading

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    A Sofia F Oliveira, Fiona L Kearns ... Adrian J Mulholland
    Short Report

    The spike protein is essential to the SARS-CoV-2 virus life cycle, facilitating virus entry and mediating viral-host membrane fusion. The spike contains a fatty acid (FA) binding site between every two neighbouring receptor-binding domains. This site is coupled to key regions in the protein, but the impact of glycans on these allosteric effects has not been investigated. Using dynamical nonequilibrium molecular dynamics (D-NEMD) simulations, we explore the allosteric effects of the FA site in the fully glycosylated spike of the SARS-CoV-2 ancestral variant. Our results identify the allosteric networks connecting the FA site to functionally important regions in the protein, including the receptor-binding motif, an antigenic supersite in the N-terminal domain, the fusion peptide region, and another allosteric site known to bind heme and biliverdin. The networks identified here highlight the complexity of the allosteric modulation in this protein and reveal a striking and unexpected link between different allosteric sites. Comparison of the FA site connections from D-NEMD in the glycosylated and non-glycosylated spike revealed that glycans do not qualitatively change the internal allosteric pathways but can facilitate the transmission of the structural changes within and between subunits.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Conor J Howard, Nathan S Abell ... Nathan B Lubock
    Research Article

    Deep Mutational Scanning (DMS) is an emerging method to systematically test the functional consequences of thousands of sequence changes to a protein target in a single experiment. Because of its utility in interpreting both human variant effects and protein structure-function relationships, it holds substantial promise to improve drug discovery and clinical development. However, applications in this domain require improved experimental and analytical methods. To address this need, we report novel DMS methods to precisely and quantitatively interrogate disease-relevant mechanisms, protein-ligand interactions, and assess predicted response to drug treatment. Using these methods, we performed a DMS of the melanocortin-4 receptor (MC4R), a G-protein-coupled receptor (GPCR) implicated in obesity and an active target of drug development efforts. We assessed the effects of >6600 single amino acid substitutions on MC4R’s function across 18 distinct experimental conditions, resulting in >20 million unique measurements. From this, we identified variants that have unique effects on MC4R-mediated Gαs- and Gαq-signaling pathways, which could be used to design drugs that selectively bias MC4R’s activity. We also identified pathogenic variants that are likely amenable to a corrector therapy. Finally, we functionally characterized structural relationships that distinguish the binding of peptide versus small molecule ligands, which could guide compound optimization. Collectively, these results demonstrate that DMS is a powerful method to empower drug discovery and development.